povidine iodine is a Topical Solution in the Human Otc Drug category. It is labeled and distributed by Dynarex Corporation. The primary component is Povidone-iodine.
| Product ID | 67777-110_6757fee4-939c-4430-8cda-77b5a8c5fad2 |
| NDC | 67777-110 |
| Product Type | Human Otc Drug |
| Proprietary Name | povidine iodine |
| Generic Name | Povidine Iodine |
| Dosage Form | Solution |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2002-01-03 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part333C |
| Labeler Name | Dynarex Corporation |
| Substance Name | POVIDONE-IODINE |
| Active Ingredient Strength | 8 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2002-01-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-01-03 |
| Marketing End Date | 2011-06-13 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-01-03 |
| Marketing End Date | 2011-06-13 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-06-13 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-06-13 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-06-13 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-06-13 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-01-03 |
| Marketing End Date | 2011-06-13 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-01-03 |
| Marketing End Date | 2011-06-13 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-06-13 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2011-06-13 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-01-03 |
| Marketing End Date | 2011-06-13 |
| Marketing Category | OTC monograph final |
| Application Number | part333C |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-01-03 |
| Marketing End Date | 2011-06-13 |
| Ingredient | Strength |
|---|---|
| POVIDONE-IODINE | 7.5 mg/mL |
| SPL SET ID: | 42831df2-5c76-4235-bfb6-abac7031d7c6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0404-5637 | povidine iodine | povidine iodine |
| 0404-5638 | povidine iodine | povidine iodine |
| 0404-5639 | povidine iodine | povidine iodine |
| 67777-110 | povidine iodine | povidine iodine |
| 67777-130 | povidine iodine | povidine iodine |
| 67777-140 | povidine iodine | povidine iodine |
| 67777-301 | povidine iodine | povidine iodine |
| 67777-419 | povidine iodine | povidine iodine |
| 67777-420 | povidine iodine | povidine iodine |
| 68016-013 | povidine iodine | povidine iodine |
| 67777-100 | povidone iodine | povidine iodine |